Duff & Phelps Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,360
| Closed | -$1.05M | – | 244 |
|
|
2024
Q1 | $1.05M | Buy |
14,360
+586
| +4% | +$45.1K | 0.01% | 206 |
|
|
2023
Q4 | $1.12M | Hold |
13,774
| – | – | 0.01% | 205 |
|
|
2023
Q3 | $1.03M | Buy |
13,774
+357
| +3% | +$27.5K | 0.01% | 202 |
|
|
2023
Q2 | $1.03M | Hold |
13,417
| – | – | 0.01% | 201 |
|
|
2023
Q1 | $1.11M | Hold |
13,417
| – | – | 0.01% | 201 |
|
|
2022
Q4 | $1.15M | Hold |
13,417
| – | – | 0.01% | 199 |
|
|
2022
Q3 | $828K | Hold |
13,417
| – | – | 0.01% | 207 |
|
|
2022
Q2 | $829K | Hold |
13,417
| – | – | 0.01% | 182 |
|
|
2022
Q1 | $798K | Hold |
13,417
| – | – | 0.01% | 187 |
|
|
2021
Q4 | $974K | Buy |
13,417
+98
| +0.7% | +$6.75K | 0.01% | 183 |
|
|
2021
Q3 | $930K | Sell |
13,319
-301
| -2% | -$21.1K | 0.01% | 185 |
|
|
2021
Q2 | $938K | Sell |
13,620
-1,170
| -8% | -$78.1K | 0.01% | 189 |
|
|
2021
Q1 | $956K | Hold |
14,790
| – | – | 0.01% | 188 |
|
|
2020
Q4 | $862K | Hold |
14,790
| – | – | 0.01% | 191 |
|
|
2020
Q3 | $935K | Hold |
14,790
| – | – | 0.01% | 179 |
|
|
2020
Q2 | $1.14M | Buy |
14,790
+260
| +2% | +$19.9K | 0.02% | 169 |
|
|
2020
Q1 | $1.09M | Buy |
14,530
+420
| +3% | +$29K | 0.02% | 159 |
|
|
2019
Q4 | $917K | Buy |
14,110
+350
| +3% | +$22.8K | 0.01% | 190 |
|
|
2019
Q3 | $872K | Hold |
13,760
| – | – | 0.01% | 186 |
|
|
2019
Q2 | $930K | Hold |
13,760
| – | – | 0.01% | 204 |
|
|
2019
Q1 | $895K | Hold |
13,760
| – | – | 0.01% | 198 |
|
|
2018
Q4 | $861K | Hold |
13,760
| – | – | 0.01% | 193 |
|
|
2018
Q3 | $1.06M | Buy |
13,760
+20
| +0.1% | +$1.51K | 0.02% | 194 |
|
|
2018
Q2 | $973K | Sell |
13,740
-220
| -2% | -$15.5K | 0.01% | 199 |
|
|
2018
Q1 | $1.05M | Sell |
13,960
-380
| -3% | -$30.2K | 0.02% | 191 |
|
|
2017
Q4 | $1.03M | Sell |
14,340
-340
| -2% | -$25.8K | 0.01% | 202 |
|
|
2017
Q3 | $1.19M | Sell |
14,680
-200
| -1% | -$15.3K | 0.02% | 201 |
|
|
2017
Q2 | $1.05M | Sell |
14,880
-1,030
| -6% | -$68.5K | 0.02% | 204 |
|
|
2017
Q1 | $1.08M | Sell |
15,910
-300
| -2% | -$21.1K | 0.02% | 207 |
|
|
2016
Q4 | $1.16M | Sell |
16,210
-740
| -4% | -$55K | 0.02% | 205 |
|
|
2016
Q3 | $1.34M | Sell |
16,950
-1,230
| -7% | -$99.9K | 0.02% | 197 |
|
|
2016
Q2 | $1.52M | Sell |
18,180
-470
| -3% | -$41.7K | 0.02% | 173 |
|
|
2016
Q1 | $1.71M | Sell |
18,650
-5,595
| -23% | -$505K | 0.03% | 161 |
|
|
2015
Q4 | $2.45M | Sell |
24,245
-1,120
| -4% | -$117K | 0.04% | 153 |
|
|
2015
Q3 | $2.49M | Sell |
25,365
-1,450
| -5% | -$161K | 0.04% | 150 |
|
|
2015
Q2 | $3.14M | Hold |
26,815
| – | – | 0.05% | 145 |
|
|
2015
Q1 | $2.63M | Sell |
26,815
-1,730
| -6% | -$176K | 0.04% | 152 |
|
|
2014
Q4 | $2.69M | Sell |
28,545
-1,660
| -5% | -$172K | 0.04% | 155 |
|
|
2014
Q3 | $3.21M | Sell |
30,205
-1,940
| -6% | -$190K | 0.05% | 143 |
|
|
2014
Q2 | $2.67M | Buy |
32,145
+575
| +2% | +$44.8K | 0.04% | 138 |
|
|
2014
Q1 | $2.24M | Sell |
31,570
-220
| -0.7% | -$17.3K | 0.04% | 142 |
|
|
2013
Q4 | $2.39M | Buy |
31,790
+1,050
| +3% | +$73.1K | 0.04% | 142 |
|
|
2013
Q3 | $1.93M | Buy |
30,740
+380
| +1% | +$22.7K | 0.03% | 171 |
|
|
2013
Q2 | $1.55M | Buy |
+30,360
| New | +$1.58M | 0.03% | 170 |
|
Other funds holding GILD
Duff & Phelps Investment Management's GILD Position: Q2 2024 in Review
Duff & Phelps Investment Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 14,360 shares — an estimated $1.05M sold.
Duff & Phelps Investment Management first reported a position in GILD in Q2 2013 and held it in 44 quarters. The position peaked at $3.21M in Q3 2014. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Duff & Phelps Investment Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Duff & Phelps Investment Management sold 14,360 Gilead Sciences shares in Q2 2024, an estimated $1.05M.
- Duff & Phelps Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 44 quarters.
- Duff & Phelps Investment Management's Gilead Sciences position peaked at $3.21M in Q3 2014.
- 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Duff & Phelps Investment Management's 13F filing for Q2 2024, filed 15 Aug 2024.